Irinotecan

CAS No. 97682-44-5

Irinotecan ( —— )

Catalog No. M16884 CAS No. 97682-44-5

Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 38 In Stock
50MG 53 In Stock
100MG 82 In Stock
500MG 206 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Irinotecan
  • Note
    Research use only, not for human use.
  • Brief Description
    Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.
  • Description
    Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Topoisomerase
  • Recptor
    Topo I
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    97682-44-5
  • Formula Weight
    586.68
  • Molecular Formula
    C33H38N4O6
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 7 mg/mL (11.93 mM)
  • SMILES
    CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Pavillard V, et al. Y ChemOthers Pharmacol. 2002, 49(4), 329-335.
molnova catalog
related products
  • 9-Methoxycamptotheci...

    9-Methoxycamptothecin (MCPT) has antitumour activities through topoisomerase inhibition.

  • SN-38

    LE-SN38 is NeoPharm’s NeoLipid liposomal formulation of SN-38, the active metabolite of irinotecan (Camptosar), a chemotherapeutic pro-drug approved for the treatment of advanced colorectal Y.

  • Pirarubicin

    Pirarubicin is an anthracycline antibiotic, and also a DNA/RNA synthesis inhibitor by intercalating into Dna and interacts with topoisomerase II, used as an antineoplastic agent.